Oric Pharmaceuticals, Inc.

ORIC Healthcare Biotechnology

In the quarter to June 2026, EPS grew 19.2% and free cash flow fell 3.42%, each against the same quarter a year earlier.

12.35 0.42 −3.29%
Market cap
$1.3B
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Total current assets
295.59 288.47 290.23 273.70
Total non-current assets
135.60 120.42 146.53 130.99
Total Assets
431.19 408.89 436.76 404.69
Total current liabilities
20.18 20.42 17.77 20.76
Total non-current liabilities
4.09 4.11 3.43 2.67
Total liabilities
24.27 24.53 21.21 23.43
Common Equity (Total)
406.92 384.36 415.56 381.26
Shareholders Equity (Total)
406.92 384.36 415.56 381.26

Show all line items

In millions of $ except per-share values · columns are period end dates